Focusing on the Frontiers, Shaping the Future | GenDx Makes a Splash at Suzhou's First In Vitro Diagnostics Industry Development Conference
updated time：2025-06-27
News & Events
Suzhou, China – June 26 – Amid the vibrant early summer energy of Suzhou, a city brimming with innovation, the highly anticipated Suzhou In Vitro Diagnostics (IVD) Industry Development Conference grandly commenced at the new site of the Suzhou Center for Disease Control and Prevention (CDC).
Guided by the Suzhou Municipal Health Commission and hosted by the Suzhou Medical Device Industry Association, with support from the Suzhou CDC, the conference established a high-level platform for industry leaders to share insights and collaboratively shape a visionary roadmap for Suzhou’s IVD sector.
As an innovation-driven company rooted in Suzhou and specializing in genetic technologies, GenDx made a striking appearance at the event, presenting its latest advancements and actively engaging in this landmark industry gathering.
Grand Opening: Charting a New Chapter for Suzhou's IVD Industry
As the city's first high-level summit dedicated to the entire in vitro diagnostics (IVD) industrial chain, this landmark event brought together elite representatives from government, industry, academia, research institutions, healthcare, and investment sectors.
During the opening ceremony, keynote speakers emphasized the strategic importance of IVD industry development for enhancing public health and advancing biomedical innovation. Several pivotal policy initiatives and development blueprints were unveiled, demonstrating Suzhou's strong commitment to establishing itself as a domestic leader and global hub for IVD excellence.
GenDx in the Spotlight: Pioneering Genetic Technologies Steal the Show
As a homegrown genetic testing innovator, GenDx made waves at the exhibition with a keynote speech by Huang Haiyan, VP of Operations. The presentation highlighted the company's latest clinical advancements in ERA (Enzymatic Recombinase Amplification)-based nucleic acid detection, anchored in its mission to "ensure future generations are protected from pathogenic infectious diseases."
Ms. Huang critically analyzed the longstanding trade-offs in traditional TB testing:
"Fast but inaccurate" (e.g., rapid serological tests)
"Accurate but slow" (e.g., culture-based methods)
She particularly addressed the limitations of the Tuberculin Skin Test (TST):
High false-positive rates (up to 60% in BCG-vaccinated populations)
Subjective interpretation variability
Phased out by most medical institutions post-2021, following China's β-Lactam Antibacterial Skin Test Guidelines
"This shift away from TST represents more than policy compliance," Huang noted. "It's a fundamental rejection of 'climbing a tree to catch fish' diagnostics. We're cutting down the 'tree of inefficiency' to make way for science-driven solutions."
GenDx's cutting-edge R&D has yielded the ERA technology-based GD-220 nucleic acid analyzer, delivering both high sensitivity and specificity. This innovative instrument achieves rapid yet accurate detection with cost-effective operation, completing tests within just 10 minutes.
GenDx is taking its products global. As shown in "Novel Isothermal Nucleic Acid Amplification Method for Detecting Malaria Parasites", their technology detected 70 positive cases among 323 malaria samples, underscoring the urgent need for rapid, accurate diagnostics - particularly in resource-limited areas facing severe outbreaks.
GenDx's GCP-30 analyzer enables:
• 30-target multiplex detection per run
• 20-minute results for timely intervention
• Simplified operation ideal for resource-limited settings
We are committed to bringing 10-minute ERA nucleic acid testing to every corner of the globe, solving critical challenges in infection detection and safeguarding public health through genomic technology," concluded VP Huang. She extended a sincere call to action: "Let us join hands across industries to build stronger global health defenses for all.
At the exhibition, attending healthcare professionals demonstrated strong interest in our Mycoplasma pneumoniae detection products, particularly praising the rapid turnaround time and user-friendly workflow. Experts further expressed significant demand for customized solutions, indicating strong willingness to pursue collaborative opportunities with GenDx.
Vision & Forward Path: Collaborating for a Precision Future
GenDx's Key Takeaways from the Summit:
01 Strong Policy Support
Suzhou's high-level commitment and substantial support for the IVD industry have created unprecedented opportunities and a fertile ecosystem for local enterprises.
02 Surging Innovation Wave
The rapid integration of cutting-edge technologies—multi-omics, microfluidics, and AI—with IVD is accelerating, making precision, intelligence, accessibility, and home-based testing clear trends. Innovation remains the eternal theme.
03 Maturing Collaborative Ecosystem
Suzhou has gathered a cluster of leading IVD companies and supporting industries, forming an increasingly robust ecosystem. Collaboration across upstream/downstream sectors and integration of industry, academia, research, and healthcare are key to accelerating innovation.
Closing Remarks
The successful hosting of Suzhou's First IVD Industry Development Summit marks not just a grand industry gathering, but also a clarion call for Suzhou's IVD sector to advance toward higher goals. GenDx is honored to participate and resonate with the pulse of this era.
Moving forward, we will continue to anchor ourselves in Suzhou's innovative landscape, striving to be a pioneer in pathogen detection technology and ushering in a new era of efficient, precise global infection diagnostics. We will:
Increase R&D investment,
Strengthen core technologies,
Deliver more high-quality products and services that meet clinical and market needs.
At the same time, we will actively embrace industry transformation, deepen collaboration with supply chain partners, and jointly drive the prosperity of Suzhou's and China's IVD industry—contributing GenDx's strength to improving disease diagnosis/treatment and advancing the "Healthy China" initiative.
Journal: Springer Nature Link
Article Title: Novel Isothermal Nucleic Acid Amplification Method for Detecting Malaria Parasites
Research Team:
Lucas Tavares de Queiroz, Barbara de Oliveira Baptista, Rebecca de Abreu-Fernandes, Carolina de Souza Faria Pereira, Juliana Aline de Souza Lemos, Hugo Amorim dos Santos de Souza, Rodrigo Medeiros Martorano, Evelyn Kety Pratt Riccio, Paulo Renato Rivas Totino, Joseli Oliveira-Ferreira, Josué da Costa Lima-Junior, Cláudio Tadeu Daniel-Ribeiro & Lilian Rose Pratt-Riccio
DOI/URL:
https://link.springer.com/article/10.1007/s00253-024-13357-2